Year | Cultivar | Treatment | Proline (μg g−1 FW) | GABA (μg g−1 FW) | PDH activity (U L−1 FW) | BADH activity (U L−1 FW) |
---|---|---|---|---|---|---|
2018 | Meixiangzhan-2 | |||||
CK | 43.14 ± 1.37a | 32.19 ± 1.52a | 13.45 ± 0.67b | 22.48 ± 0.35a | ||
La | 34.12 ± 0.43b | 25.63 ± 1.10b | 17.58 ± 0.72a | 18.54 ± 0.43b | ||
Xiangyaxiangzhan | ||||||
CK | 40.59 ± 0.62a | 35.73 ± 1.15a | 13.46 ± 1.15b | 21.01 ± 0.45a | ||
La | 31.19 ± 0.53b | 28.08 ± 1.71b | 18.27 ± 1.07a | 17.13 ± 0.84b | ||
2019 | Meixiangzhan-2 | |||||
CK | 41.98 ± 0.84a | 34.51 ± 0.23a | 12.04 ± 0.91b | 21.51 ± 0.39a | ||
La | 33.21 ± 1.20b | 24.12 ± 1.57b | 18.89 ± 1.27a | 17.39 ± 0.59b | ||
Xiangyaxiangzhan | ||||||
CK | 43.31 ± 2.67a | 39.16 ± 1.28a | 13.23 ± 1.09b | 20.99 ± 0.28a | ||
La | 32.77 ± 1.71b | 25.89 ± 2.54b | 16.40 ± 0.32a | 18.59 ± 0.25b |